Measles
📧 Sign up to get email alerts when something new happens for Measles.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR [Phase 4]
Phase 4 trial assessing whether the measles-mumps-rubella vaccine virus is excreted in breast milk after postpartum vaccination; the study s…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months [NA]
A completed trial assessing whether supplementation with SQ-LNS incentives can boost measles vaccination coverage in children aged 6-23 mont…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age [Phase 4]
A Phase 4 trial assessing how limiting measles vaccination to children under 12 months affected overall mortality in a national program.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Trial of Additional Measles Vaccine to Reduce Child Mortality [Phase 4]
A Phase 4 clinical trial assessing whether an additional measles vaccine dose can reduce child mortality has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso. [Phase 4]
Phase 4 clinical trial in Burkina Faso evaluating an additional measles vaccine to reduce child mortality has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
This clinical trial update examines five-year antibody persistence after vaccination with IPV, MMR, and HepA-L vaccines. The study is not ye…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months [Phase 3]
Phase 3 trial comparing SIBP's Measles-Mumps-Rubella vaccine with GlaxoSmithKline's MMR vaccine in children aged 9-11 months has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) [Phase 4]
Phase 4 trial evaluating immunogenicity when a Japanese encephalitis vaccine is co-administered with a Measles-Mumps-Rubella vaccine; the st…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age [Phase 4]
A Phase 4 CDC-sponsored study assessed the immunogenicity of the Measles-Rubella vaccine in infants at 6 and 9 months, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age [Phase 2]
Phase 2 trial comparing immune response and safety of a combined measles, mumps, rubella, and varicella vaccine against a marketed MMRV vacc…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Barriers and Facilitators to MMR Vaccination Among Healthcare Workers
This completed clinical trial examines barriers and facilitators to MMR vaccination among healthcare workers. The study focuses on preventin…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Study of Live Attenuated Varicella Vaccine Co-administered with MMR Vaccine or DTaP Vaccine [Phase 4]
Phase 4 trial update evaluating a live attenuated varicella vaccine co-administered with MMR or DTaP vaccines; study status is NOT_YET_RECRU…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months [Phase 3]
A Phase 3 clinical trial is evaluating non-interference between the Measles-Rubella (MR) vaccine and the Yellow Fever vaccine in Bangladeshi…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience
A completed single-center clinical study assessing pediatric measles cases in 2019, summarizing patient characteristics and outcomes.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal conjugate vaccine when administered concomitantly with routine pediatri…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children [Phase 4]
A Phase 4 trial evaluates whether vaccination campaigns using measles and oral polio vaccines influence general hospital admissions and mort…
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of MMR Vaccination [NA]
This completed trial evaluated how varied outreach methods affect appointment scheduling, appointment completion, and receipt of the Measles…
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Measles and BCG Vaccines for Mother and Child [Phase 4]
Phase 4 clinical trial update investigating measles and BCG vaccines for mother and child, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination [Phase 3]
A Phase 3 clinical trial update evaluating immune responses in individuals fully vaccinated against measles, mumps, and rubella and response…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines [Phase 4]
Phase 4 trial updating immunogenicity and safety of an inactivated SARS-CoV-2 vaccine when coadministered with two attenuated vaccines, focu…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial [Phase 1, Phase 2]
Phase 1/2 trial evaluating a microneedle patch for measles and rubella vaccination completed.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine [Phase 4]
Phase 4 trial update examining immunogenicity and safety of HPV vaccine co-administered with MMR vaccine.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: MMR at 6 Months Trial [Phase 4]
A Phase 4 clinical trial update for the measles-mumps-rubella vaccine completed its study.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group [Phase 2]
Phase II multicenter study comparing seroconversion after single-dose versus two-dose measles vaccination in HIV-infected and uninfected chi…
-
CLINICAL_TRIALS trial_result · 2021-10-18Clinical Trial Update: Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011) [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of concomitant MMR rHA and VARIVAX given intramuscularly versus subcutaneously.